2019-02-12 - CMAG Meeting
Tuesday 12th February 2019 2000UTC
Meeting Details: https://snomed.zoom.us/j/231295710
Information on using Zoom: Starting with ZOOM
Attendees
@Cathy Richardson - attended
@Monica Harry - attended
@Former user (Deleted) - did not attend
@Former user (Deleted) - did not attend
@Daniel Karlsson - attended
@Former user (Deleted) -attended
@Elze de Groot (Unlicensed) -attended
@Linda Parisien -did not attend
@Jostein Ven (Unlicensed) - attended
@Camilla Wiberg Danielsen - did not attend
@Theresa Barry -attended
@Matt Cordell - attended
@Former user (Deleted) - attended
Apologies
@Camilla Wiberg Danielsen
@Linda Parisien
@Former user (Deleted)
Minutes:
Page will be updated with summary notes from meeting.
Please see recording for full details.
Objectives
Discussion items (In draft)
Description | Owner | Notes | Action | |
|---|---|---|---|---|
| 1 | Welcome | @Cathy Richardson |
|
|
| 2 | Apologies/conflicts of interest | @Cathy Richardson |
|
|
| 3 | Administrative | @Cathy Richardson |
|
|
| 4 | Action List | @Cathy Richardson |
| |
| 5 | Member Forum update | @Linda Parisien |
|
|
| 6 | Quality Initiative | @Former user (Deleted) |
|
|
| 7 | Review of Administrative Content | @Former user (Deleted) @Monica Harry |
|
|
| 8 | NMO and “Other” ethnic non-mixed concepts | @Monica Harry |
|
|
| 9 | SNOMED content derived from ICD 9 and READ codes | @Elze de Groot (Unlicensed) |
|
|
| 10 | April meeting | Group |
|
|
| 11 | Any other business | ALL |
|
|
Meeting Files
Previous Meetings
Comments
Hi,
I'd like to know if members of this AG would be interested to discuss the finalised proposed National Extension Drug Model for member countries at the April session?
In Canada, we are interested in enhancing our Vaccine Model and we want to comply/use the International Guidelines, but we also want to make sure that all relevant components will be available to the countries that will want to extend from core. We'd also want to know where is the immunization focus in the Drug Project.
Here is the referenced document: SNOMED CT Drug Model for supporting National Extension V1.0.pdf
Here is the Confluence Reference Documentation - Medicinal Product Model Page, for additional information.
Thank you!
For questions about ICD9-CM, NLM recommends you contact Donna Pickett from the National Center for Heath Statistics (NCHS), part of the Center for Disease Prevention and Control (CDC).
Donna Pickett, RHA, MPH
Medical Systems Administrator Classifications & Public Health Data Standards Staff
Office of the Director
National Center for Health Statistics, CDC
3311 Toledo Road
Hyattsville, MD 20782-2002
Phone: 301-458-4434
Email: dfp4@cdc.gov
Hi Cathy,
I will not be able to join the call today, but I'd like to provide the group with some update from the MF held on Jan31.
The briefing note on the "NMO and “Other” ethnic non-mixed (NMO)" was presented at the last Member Forum meeting, and I see that the briefing note that will be presented today has been partially modified to reflect some of the discussion we have had:
There was a common agreement that the concept that contains "other" in their descriptions should be inactivated
There was also many voices that requested that the other ethnical concepts (those that were not ambiguous) be kept in the international version, because it is most likely that this content, if inactivated at the core level, will need to be recreated in each NRC, which will duplicate efforts and additionnaly, will go against the interoperability purpose.
Another topic that was presented, and I don't see on today's agenda is the "BN Approach to Releasing Derivatives", presented by Jane Millar: https://drive.google.com/file/d/1RDabl5NzPl3qdSEUjj4P3aGHfYCWt9WN/view
The SI proposal is to update and publish once a year most of the subsets they published.
Here are some of the comments provided at the MF:
Has SI envisaged to create Query refset for these subsets? So implementers that have adopted these subsets, can run their updates when core version is updated. The maintenance of subsets based on filters is way more effective and sustainable than a manual kind of maintenance.
Has SI envisaged that someone else than SI could maintain the subsets?
There will soon be a requirement for increasing the releases… even going to continuous publication or out of cycle releases only when there are changes. Should SI provide the subsets more as a service so MF can help themselves?
Linda